{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:52:10Z","timestamp":1781920330829,"version":"3.54.5"},"reference-count":28,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Transgender (TGD) adults experience healthcare disparities across multiple domains, yet care for steatotic liver disease (SLD) remains uninvestigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Evaluate whether TGD adults with SLD receive equitable liver-related care compared with cisgender (CGD) adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective cohort study conducted at a tertiary medical center (2015-2025). Adults with SLD were identified by a 2-step process (ICD-10 codes, manual chart review). Patients with other causes of liver disease and missing data were excluded. TGD status was defined by ICD-10 codes for gender dysphoria, documented gender incongruence or use of gender affirming hormone therapy. Controls and cases were selected from the same cohort with a 2:1 sampling ratio. Primary outcomes, gastroenterology consultation, hepatology assessment (FIB-4, elastography, or biopsy), and advanced workup, were analyzed using logistic regression adjusting for age and cardiometabolic covariates. An age restricted (30-60) sensitivity analysis was performed. Secondary outcomes included viral hepatitis screening\/vaccination, SLD-directed therapies, and 5-year BMI trajectories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 254 adults (85 TGD, 169 CGD), TGD individuals were younger (36.0 vs 57.0 years, P &amp;lt; .001) with higher MASLD prevalence (91.8% vs 77.5%, P = .05). TGD status was associated with lower odds of gastroenterology consultation (aOR 0.41; 95% CI .18\u2013.93), any hepatology assessment (aOR 0.35; 95% CI .18\u2013.70), advanced hepatology workup (aOR 0.34; 95% CI .17\u2013.69), with robust findings in sensitivity analysis. GLP-1 agonist prescriptions were lower (9.4% vs 19.5%, P = .03), and BMI increased vs controls (P &amp;lt; .001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TGD adults with SLD experience substantial disparities in care, requiring integrated, inclusive pathways to advance health equity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvag129","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:47:41Z","timestamp":1781178461000},"source":"Crossref","is-referenced-by-count":0,"title":["Disparities in liver-related care among transgender adults with steatotic liver disease: a retrospective cohort study"],"prefix":"10.1210","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3547-5312","authenticated-orcid":false,"given":"Maria","family":"Ortega Abad","sequence":"first","affiliation":[{"name":"Endocrinology and Metabolism Institute, Cleveland Clinic , 9500 Euclid Avenue, Cleveland, OH 44195 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Sierra","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cleveland Clinic , Cleveland, OH 44195 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Duong","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University , Palo Alto, CA 94305 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Correa","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism Institute, Cleveland Clinic , 9500 Euclid Avenue, Cleveland, OH 44195 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"4","key":"2026061921262200500_bvag129-B1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"2026061921262200500_bvag129-B2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1210\/jc.2015-3444","article-title":"Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies","volume":"101","author":"Loomis","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026061921262200500_bvag129-B3","doi-asserted-by":"crossref","first-page":"e0515","DOI":"10.1097\/HC9.0000000000000515","article-title":"Comparison blood-based liver fibrosis scores Mount Sinai Health System, MASLD registry, NHANES 2017-2020 study","volume":"8","author":"Chen","year":"2024","journal-title":"Hepatol Commun"},{"issue":"6","key":"2026061921262200500_bvag129-B4","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"10","key":"2026061921262200500_bvag129-B5","doi-asserted-by":"crossref","first-page":"e189953","DOI":"10.1172\/JCI189953","article-title":"Disease classification, diagnostic challenges, and evolving clinical trial design in MASLD","volume":"135","author":"Munk Lauridsen","year":"2025","journal-title":"J Clin Invest"},{"key":"2026061921262200500_bvag129-B6","volume-title":"How Many Adults and Youth Identify as Transgender in the United States?","author":"Herman","year":"2025"},{"key":"2026061921262200500_bvag129-B7","volume-title":"The Report of the 2015 U.S. Transgender Survey","author":"James","year":"2016"},{"issue":"2","key":"2026061921262200500_bvag129-B8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MED.0000000000000227","article-title":"Barriers to healthcare for transgender individuals","volume":"23","author":"Safer","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"8","key":"2026061921262200500_bvag129-B9","first-page":"513","article-title":"Geographic and individual differences in healthcare access for U.S. Transgender adults","volume":"26","author":"White Hughto","year":"2016","journal-title":"Ann Epidemiol"},{"issue":"3","key":"2026061921262200500_bvag129-B10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.amepre.2017.11.009","article-title":"Gender identity disparities in cancer screening behaviors","volume":"54","author":"Tabaac","year":"2018","journal-title":"Am J Prev Med"},{"issue":"7","key":"2026061921262200500_bvag129-B11","first-page":"1019","article-title":"Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model","volume":"11","author":"Sterling","year":"2022","journal-title":"Transl Androl Urol"},{"issue":"6","key":"2026061921262200500_bvag129-B12","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3390\/genes13060966","article-title":"Associations of sex steroids and sex hormone-binding globulin with non-alcoholic fatty liver disease: a population-based study and meta-analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Genes (Basel)"},{"issue":"2","key":"2026061921262200500_bvag129-B13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/liv.15786","article-title":"Endogenous sex hormones and nonalcoholic fatty liver disease in US adults","volume":"44","author":"Kim","year":"2024","journal-title":"Liver Int"},{"issue":"6","key":"2026061921262200500_bvag129-B14","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.cgh.2020.09.045","article-title":"Testosterone is associated with nonalcoholic steatohepatitis and fibrosis in premenopausal women with NAFLD","volume":"19","author":"Sarkar","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"2026061921262200500_bvag129-B15","first-page":"S456","article-title":"Associations of depression with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"78","author":"Kang","year":"2023","journal-title":"J Hepatol"},{"issue":"3","key":"2026061921262200500_bvag129-B16","first-page":"412","article-title":"Health disparities in gastroenterology and hepatology: a systematic review","volume":"166","author":"V\u00e9lez","year":"2024","journal-title":"Gastroenterology"},{"key":"2026061921262200500_bvag129-B17","first-page":"307","volume-title":"Handbook of Epidemiology","author":"Breslow","year":"2014"},{"issue":"5","key":"2026061921262200500_bvag129-B18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1037\/0033-2909.129.5.674","article-title":"Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence","volume":"129","author":"Meyer","year":"2003","journal-title":"Psychol Bull"},{"issue":"10042","key":"2026061921262200500_bvag129-B19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(16)00684-X","article-title":"Global health burden and needs of transgender populations: a review","volume":"388","author":"Reisner","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"2026061921262200500_bvag129-B20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/er.2018-00158","article-title":"Reproductive endocrinology of nonalcoholic fatty liver disease","volume":"40","author":"Grossmann","year":"2019","journal-title":"Endocr Rev"},{"issue":"4","key":"2026061921262200500_bvag129-B21","doi-asserted-by":"crossref","first-page":"e257115","DOI":"10.1001\/jamanetworkopen.2025.7115","article-title":"Mental and physical health among Danish transgender persons compared with cisgender persons","volume":"8","author":"Glintborg","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026061921262200500_bvag129-B22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2020.09.073","article-title":"Association between depression and nonalcoholic fatty liver disease: contributions of insulin resistance and inflammation","volume":"278","author":"Lee","year":"2021","journal-title":"J Affect Disord"},{"key":"2026061921262200500_bvag129-B23","first-page":"112","article-title":"Association between depression and non-alcoholic fatty liver disease: a Mendelian randomization study","volume":"334","author":"Liu","year":"2023","journal-title":"J Affect Disord"},{"key":"2026061921262200500_bvag129-B24","volume-title":"Injustice at Every Turn: A Report of the National Transgender Discrimination Survey","author":"Grant","year":"2011"},{"issue":"4","key":"2026061921262200500_bvag129-B25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/1468-0009.12297","article-title":"Barriers to care among transgender and gender nonconforming adults","volume":"95","author":"Gonzales","year":"2017","journal-title":"Milbank Q"},{"issue":"5","key":"2026061921262200500_bvag129-B26","doi-asserted-by":"crossref","first-page":"e1033","DOI":"10.1542\/peds.2006-1730","article-title":"Health insurance across vulnerable ages: patterns and disparities from adolescence to the early 30 s","volume":"119","author":"Adams","year":"2007","journal-title":"Pediatrics"},{"issue":"10S2","key":"2026061921262200500_bvag129-B27","doi-asserted-by":"crossref","first-page":"S610","DOI":"10.14309\/01.ajg.0001138808.23421.9f","article-title":"Use of EMR automated FIB 4 as a tool for MASLD screening in primary care","volume":"120","author":"Winte","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"2026061921262200500_bvag129-B28","first-page":"372","article-title":"Evolving primary care utilization of transgender and gender-nonconforming people at a community sexual health clinic","volume":"7","author":"Jadwin-Cakmak","year":"2022","journal-title":"Transgend Health"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvag129\/68522473\/bvag129.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/7\/bvag129\/68522473\/bvag129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/7\/bvag129\/68522473\/bvag129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:26:32Z","timestamp":1781918792000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvag129\/8707589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,6,3]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvag129","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,6,3]]},"article-number":"bvag129"}}